Sébastien Jenni, F. Ponsot, P. Baroux et al.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 248 (2021) 119179
1
residue was dissolved in a (2:3, v/v) mixture of 0.1% aq. TFA and
MeCN (4 mL) and purified twice by semi-preparative RP-HPLC
687, 639, 600, 583, 553, 511, 496, 469, 434, 413; H NMR
3
3
(500 MHz, CDCl
3 H-H
): d = 9.20 (d, JH-H = 6.4 Hz, 2H), 8.57 (d, J =
3
(
system D, 1 injection, t
R
= 46.0–50.0 min of collected fractions
6.4 Hz, 2H), 7.89 (m, 4H), 7.81 (d,
JH-H = 8.7 Hz, 2H), 7.70
JH-H = 8.2 Hz, 2H), 6.75 (d, JH-H =
3
3
3
containing the desired compound). The product-containing frac-
(d, JH-H = 8.7 Hz, 2H), 7.62 (d,
tions were lyophilized to give TFA salt of 7 as a purple solid
9.2 Hz, 2H), 6.02 (s, 2H), 3.48 (s, 3H), 3.36 (s, 3H), 3.11 (s, 6H);
C NMR (151 MHz, CD CN): d 162.1, 161.1, 153.9, 153.3, 153.3,
3
1
3
(
4.9 mg, 6.7
l
mol, yield 12% based on mass percentage of
1
TFA = 17% determined by ionic chromatography, 1.1 TFA).
NMR (500 MHz, DMSO d
6
2
H
=
144.7, 143.1, 143.0, 139.3, 133.4, 132.2, 131.3, 130.4, = 126.8,
126.5, 126.1, 125.1, 122.7, 115.5, 111.6, 109.7, 63.9, 39.5,
3
6
): d 13.34 (brs, 2H), 9.36 (d,
J
H-H
3
H-H = 6.5 Hz, 2H), 8.33 (d, 3
29.2, 29.1; 19F NMR (565 MHz, CD
.5 Hz, 2H), 8.47 (d,
H), 7.88 (m, 2H), 7.82 (m, 4H), 6.04 (s, 2H), 4.59 (s, 2H), 4.53 (s,
H); 19F NMR (565 MHz, DMSO d
-TFA); full
J
J
H-H = 8.1 Hz,
3
CN)
-free TFA); HPLC (system
R
= 4.9 min (purity 97% at 260 and 98% at 460 nm); UV–vis
d = -75.9 (3F,
CF
3
-trifluoroacetate), ꢁ76.5 (0.05F, CF
3
2
6
): d = ꢁ73.5 (3F, CF
3
A): t
1
3
spectroscopic characterization of this probe through C NMR mea-
surements was not completed immediately, and an unexpected degra-
(recorded during RP-HPLC analysis): kmax = 280 and 452 nm; LRMS
(ESI+, recorded during RP-HPLC analysis): m/z 633.4 and 635.4
1
3
+
+
dation occurring at the solid state has prevented us to record C NMR
spectrum. HPLC (system A): t = 3.8 min (purity 98% at 260 nm and
00% at 520 nm); UV–vis (recorded during RP-HPLC analysis):
max = 271, 330 and 518 nm; LRMS (ESI+, recorded during RP-
[M] , calcd for C34
6
H30BrN O
2
633.2 and 635.2.
R
1
k
0
2
.5.3. N-(4-Nitrobenzyl)pyridinium mono-(4 -pyridyl)-DPP N,N’-
dimethyl 9
+
+
4 8
HPLC analysis): m/z 619.2 and 621.2 [M] , calcd for C28H20BrN O
To a solution of 18 (20.0 mg, 51 mmol, 1.0 equiv.) in dry MeCN
3 mL) was added 4-nitrobenzyl bromide (32.7 mg, 150 mmol, 2.9
6
19.1 and 619.2.
(
equiv.). The resulting reaction mixture was stirred at 75 °C under
overnight and the disappearance of the starting material was
0
2
.5. Synthesis of unsymmetrical mono-(4 -pyridyl)-DPP dye 18 and
N
2
related AzoR- and NTR-sensitive probes 8 and 9
checked by RP-HPLC (system A). Thereafter, the mixture was evap-
orated under reduced pressure, re-dissolved in a (1:3, v/v) mixture
of 0.1% aq. TFA and MeCN (4 mL) and purified by semi-preparative
0
2
.5.1. Mono-(4 -pyridyl)-DPP N,N’- dimethyl 18
0
A suspension of mono-(4 -pyridyl)-DPP pigment 5 (300 mg,
.81 mmol, 1.0 equiv.) and tBuOK (229 mg, 2.04 mmol, 2.5 equiv.)
R
RP-HPLC (system F, 1 injection, t = 43.0–50.0 min of collected frac-
0
tions containing the desired compound). The product-containing
fractions were lyophilized to give TFA salt of 9 as a purple solid
(8.3 mg, 12 mmol, yield 24% based on mass percentage of
TFA = 22% determined by ionic chromatography, 1.3 TFA). IR
in dry NMP (30 mL) was stirred at RT under nitrogen for 15 min.
MeI (151 mL, 2.44 mmol, 3.0 equiv.) was added and the mixture
was stirred at RT under N
the product was extracted with toluene three times. The combined
organic layers were dried over anhydrous Na SO , filtered and the
2 2
for 1 h. Deionized H O was added and
(ATR):
m = 3046, 2923, 1670, 1630, 1564, 1520, 1487, 1430, 1402,
1374, 1347, 1289, 1197, 1165, 1125, 1072, 1043, 1005, 830, 798,
2
4
1
solvent was evaporated under reduced pressure. Compound 18
759, 736, 718, 705, 686, 619, 521, 489, 441, 411; H NMR
was obtained as a dark-orange solid (141 mg, 0.35 mmol, yield
3
(500 MHz, CD CN): d = 8.84 (d, J = 7.1 Hz, 2H), 8.54 (d, J = 7.1 Hz,
4
1
7
4
2
4%). IR (ATR):
m
= 3046, 2850, 1650, 1587, 1539, 1494, 1468,
2H), 8.30 (d, J = 8.8 Hz, 2H), 7.92 (d, J = 8.7 Hz, 2H), 7.80 (d,
J = 8.7 Hz, 2H), 7.69 (d, J = 8.8 Hz, 2H), 5.85 (s, 2H), 3.37 (s, 3H),
425, 1397, 1363, 1283, 1218, 1098, 1071, 1045, 1006, 824, 757,
40, 729, 701, 687, 647, 582, 554, 535, 519, 496, 469, 434, 423,
1
3
3.30 (s, 3H); C NMR (126 MHz, CD
3
CN): d = 162.9, 161.8, 154.2,
1
3
12, 402; H NMR (500 MHz, CDCl
3
): d = 8.90 (d,
J
H-H = 5.5 Hz,
145.8, 144.0, 140.3, 139.9, 133.0, 132.1, 131.1, 127.6, 127.4,
3
3
19
H), 8.11 (d,
JH-H = 5.5 Hz, 2H), 7.84 (d,
J
H–H = 8.6 Hz, 2H), 7.75
126.8, 125.1, 63.7, 29.9, 29.9; F NMR (565 MHz, CD
3
CN): d = -
3
13
(
d,
J
H-H = 8.6 Hz, 2H), 3.44 (s, 3H), 3.39 (s, 3H); C NMR
): d = 162.3, 162.0, 150.2 (2C), 149.8, 144.7,
35.5, 132.4 (2C), 130.8 (2C), 126.9, 126.3, 122.5 (2C), 111.4,
09.4, 29.6, 29.5; HPLC (system A): t = 4.7 min (purity 99% at
60 nm and 100% at 460 nm); UV–vis (recorded during RP-HPLC
75.5 (3F, CF -trifluoroacetate; HPLC (system A): t = 3.4 min (purity
3
R
(
126 MHz, CDCl
3
99% at 260 nm, 98% at 460 nm and 100% at 520 nm); UV–vis
(recorded during RP-HPLC analysis): kmax = 264 and 539 nm; LRMS
(ESI+, recorded during RP-HPLC analysis): m/z 531.2 and 533.3
1
1
2
R
+
+
[M] , calcd for C26H20BrN O 531.1 and 533.1.
4
4
analysis): kmax = 264 and 485 nm; LRMS (ESI+, recorded during
+
15
RP-HPLC analysis): m/z 396.1 and 398.1 [M+H] , calcd for C19H -
2
.6. Synthesis of PGA-sensitive probe 10 based on unsymmetrical
+
BrN
3
O
2
396.0 and 398.0.
0
mono-(4 -pyridyl)-DPP 18
2
.5.2. N-(4-[2-[4-(dimethylamino)phenyl]diazenyl]-benzyl)
To a solution of 18 (20.0 mg, 51 mmol, 1.0 equiv.) in dry MeCN
(5 mL) was added benzyl bromide 20 (46.0 mg, 150 mmol, 2.9
equiv.). The resulting reaction mixture was stirred at 75 °C under
0
pyridinium mono-(4 -pyridyl)-DPP N,N’- dimethyl 8
To a solution of 18 (22.0 mg, 56 mmol, 1.0 equiv.) in dry DMF
5 mL), benzyl bromide 19 (53.0 mg, 167 mmol, 3.0 equiv.) was
(
2
N for 12 h. The disappearance of the starting material was checked
added. The resulting mixture was stirred at 75 °C under N
2 h. Thereafter, this mixture was evaporated under reduced pres-
sure and the resulting residue was purified by column chromatog-
raphy over silica gel (VWR technical grade, 40–63 m, #84814.360,
2
for
by RP-HPLC (system A) and the mixture was evaporated under
reduced presssure. The residue was dissolved in a (1:3, v/v) mix-
ture of 0.1% aq. TFA and MeCN (4 mL) and purified by semi-
1
l
R
preparative RP-HPLC (system F, 1 injection, t = 47.5–55.5 min of
eluent: a step gradient of MeOH in DCM as eluent from 5% to 15%).
The isolated product was dissolved in a (1:3, v/v) mixture of 0.1%
aq. TFA and MeCN and (4 mL) and subjected to a further purifica-
collected fractions containing the desired compound). The
product-containing fractions were lyophilized to give TFA salt of
10 as a purple solid (9.7 mg, 12.4 mmol, yield 25% based on mass
percentage of TFA = 20% determined by ionic chromatography,
tion by semi-preparative RP-HPLC (system F, 1 injection, t
R
= 55.0–
6
3.0 min of collected fractions containing the desired compound).
1.4 TFA). IR (ATR):
m = 1672, 1631, 1602, 1537, 1515, 1488, 1416,
The product-containing fractions were lyophilized to give TFA salt
of 8 as a purple solid (7.9 mg, 9.5 mmol, yield 17% based on mass
percentage of TFA = 24% determined by ionic chromatography,
1373, 1199, 1131, 1073, 1044, 1006, 833, 798, 755, 719, 625,
517, 433, 412; H NMR (500 MHz, CD CN): d = 8.91 (s, 1H), 8.78
3
(d, J = 7.1 Hz, 2H), 8.46 (d, J = 7.1 Hz, 2H), 7.90 (d, J = 8.7 Hz,
2H), 7.79 (d, J = 8.6 Hz, 2H), 7.70 (d, J = 8.7 Hz, 2H), 7.44 (d,
J = 8.6 Hz, 2H), 7.38–7.29 (m, 4H), 7.28–7.24 (m, 1H), 5.66 (s,
1
1
.8 TFA). IR (ATR):
m 2923, 1674, 1629, 1599, 1519, 1488, 1429,
1
365, 1200, 1136, 1073, 1043, 1005, 943, 830, 798, 756, 720,
5